Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the ...
Hims & Hers Health (HIMS) stock rocketed higher today after the telehealth platform operator announced plans to introduce ...
Hims & Hers is introducing at-home laboratory testing, expanding its platform to offer deeper health insights and more ...
After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers (HIMS) ...
Hims & Hers announced its plans to introduce at-home lab testing through its platform. The company has acquired an at-home lab testing ...
Hims & Hers Health shares reached another all-time high after the company said it plans to introduce at-home lab testing through its platform after buying an at-home testing facility, Sigmund NJ.
New service will enable blood testing for hormone levels, cardiac risk, thyroid function, and more using a blood lancet.
By acquiring Sigmund NJ LLC, known as Trybe Labs, Hims & Hers will be able "to support at-home blood draws and more ...
Hims & Hers Health, Inc., the leading health and wellness platform, today announced its plans to introduce at-home lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results